FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs LHRH receptor agonists (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms FASTR
Most Recent Events
- 09 Aug 2018 Biomarkers information updated
- 29 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 27 Sep 2011 New trial record